GLP-1s may aid bone health as well as weight loss in type 2 diabetes

• People with type 2 diabetes can be at a higher risk for broken bones when they use weight-loss strategies.
• Semaglutide is a medication that can help with diabetes management and weight loss.
• A recent study found that, compared to other weight-loss medications, semaglutide appeared to help the most with weight loss and was linked to a 15% decrease in fractures.

The use of weight-loss medications like semaglutide is becoming more and more popular.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used to help with type 2 diabetes management and weight loss. One area of less research is how semaglutide impacts bone health.

Recent study results shared at the Endocrine Society meeting ENDO 2026 indicate that semaglutide was linked to higher weight loss and a 15% decrease in broken bones when it was compared to other weight loss medications.

These findings — which are yet to appear in a peer-reviewed journal — suggest that semaglutide may be beneficial for bone health.